Allergan has bought Zeltiq Aesthetics, the company behind CoolSculpting, for $2.48 billion. One of the giants in the aesthetics industry, Allergan carries key brands like Botox Cosmetic, Juvéderm and Latisse.
“By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings, we are creating a world-class aesthetics business,” Allergan CEO Brent Saunders said in a statement. “With CoolSculpting, our offerings to plastic surgeons, dermatologists and aesthetic practitioners will now extend to three of the largest and fastest-growing segments of their practices, putting Allergan in a unique position to provide expanded customer service, and help meet the needs of patients.”
Allergan has been acquiring several companies in the last year. While $160 billion merger with Pfizer collapsed in April, purchased regenerative medicine business LifeCell Corp. for $2.9 billion and biotech company Vitae Pharmaceuticals for $1.5 billion.
“Allergan’s world-class medical aesthetics products, global footprint, history and commitment to developing best-in-class aesthetic treatments makes the company ideally suited to realize the maximum commercial potential of the Zeltiq controlled-cooling technology platform,” Zeltiq CEO Mark Foley said.